• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物制品制造的哺乳动物细胞培养。

Mammalian cell cultures for biologics manufacturing.

机构信息

Upstream Development, Alexion Pharmaceuticals, Cheshire, CT, 06410, USA,

出版信息

Adv Biochem Eng Biotechnol. 2014;139:1-9. doi: 10.1007/10_2013_255.

DOI:10.1007/10_2013_255
PMID:24258145
Abstract

Biopharmaceuticals represent a growing sector of the pharmaceutical industry, and are used for a wide range of indications, including oncology and rheumatology. Cultured mammalian cells have become the predominant expression system for their production, partly due to their ability to complete the posttranslational modifications required for drug safety and efficacy. Over the past decade, the productivity of mammalian cell culture production processes has growth dramatically through improvements in both volumetric and specific productivities. This article presents an overview of the biologics market, including analysis of sales and approvals; as well as a review of industrial production cell lines and cell culture operations.

摘要

生物制药是医药行业不断发展的一个领域,广泛用于各种适应症,包括肿瘤学和风湿病学。由于能够完成药物安全性和疗效所需的翻译后修饰,因此培养的哺乳动物细胞已成为其生产的主要表达系统。在过去的十年中,通过提高体积产率和比产率,哺乳动物细胞培养生产工艺的生产力得到了显著提高。本文概述了生物制药市场,包括对销售额和批准情况的分析;以及对工业生产细胞系和细胞培养操作的回顾。

相似文献

1
Mammalian cell cultures for biologics manufacturing.用于生物制品制造的哺乳动物细胞培养。
Adv Biochem Eng Biotechnol. 2014;139:1-9. doi: 10.1007/10_2013_255.
2
Mammalian cell culture capacity for biopharmaceutical manufacturing.哺乳动物细胞培养在生物制药生产中的应用。
Adv Biochem Eng Biotechnol. 2014;139:185-225. doi: 10.1007/10_2013_215.
3
Biotech drug market steadily expands.生物科技药物市场稳步扩张。
Nat Biotechnol. 2005 Dec;23(12):1466. doi: 10.1038/nbt1205-1466.
4
'Biosimilar' drugs poised to penetrate market.生物类似药有望打入市场。
Nature. 2010 Nov 4;468(7320):18-9. doi: 10.1038/468018a.
5
Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.现行法律下通用生物制品简化审批的潜在途径以及对该法律的拟议改革。
Food Drug Law J. 2007;62(1):77-137.
6
The challenge of follow-on biologics for treatment of multiple sclerosis.生物类似药治疗多发性硬化症面临的挑战。
Neurology. 2009 Aug 18;73(7):552-9. doi: 10.1212/WNL.0b013e3181b2a6ce.
7
Market exclusivity for biologics.生物制品的市场独占权。
N Engl J Med. 2010 Feb 18;362(7):661; author reply 661-2. doi: 10.1056/NEJMc0912463.
8
The biotech drug market.生物科技药物市场。
Nat Biotechnol. 2004 Dec;22(12):1496. doi: 10.1038/nbt1204-1496.
9
Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.通过开发已批准药物的新用途进行创新:补充适应症营销批准的趋势。
Clin Ther. 2013 Jun;35(6):808-18. doi: 10.1016/j.clinthera.2013.04.004. Epub 2013 May 28.
10
Recombinant protein therapeutics--success rates, market trends and values to 2010.重组蛋白疗法——截至2010年的成功率、市场趋势及价值
Nat Biotechnol. 2004 Dec;22(12):1513-9. doi: 10.1038/nbt1204-1513.

引用本文的文献

1
Predicting cell properties with AI from 3D imaging flow cytometer data.利用人工智能从三维成像流式细胞仪数据预测细胞特性。
Sci Rep. 2025 Feb 17;15(1):5715. doi: 10.1038/s41598-024-80722-6.
2
Engineering CAR-T Therapeutics for Enhanced Solid Tumor Targeting.工程化嵌合抗原受体T细胞疗法以增强实体瘤靶向性
Adv Mater. 2025 Jun;37(23):e2414882. doi: 10.1002/adma.202414882. Epub 2025 Jan 2.
3
Sodium acetate increases the productivity of HEK293 cells expressing the ECD-Her1 protein in batch cultures: experimental results and metabolic flux analysis.
在分批培养中,醋酸钠可提高表达ECD-Her1蛋白的HEK293细胞的生产力:实验结果与代谢通量分析。
Front Bioeng Biotechnol. 2024 Apr 10;12:1335898. doi: 10.3389/fbioe.2024.1335898. eCollection 2024.
4
Enhancing Antibody-Specific Productivity: Unraveling the Impact of XBP1s Overexpression and Glutamine Availability in SP2/0 Cells.提高抗体特异性生产力:解析XBP1s过表达和谷氨酰胺可用性对SP2/0细胞的影响
Bioengineering (Basel). 2024 Feb 21;11(3):201. doi: 10.3390/bioengineering11030201.
5
Parametric Study of Jet/Droplet Formation Process during LIFT Printing of Living Cell-Laden Bioink.载有活细胞的生物墨水在LIFT打印过程中射流/液滴形成过程的参数研究。
Micromachines (Basel). 2021 Nov 16;12(11):1408. doi: 10.3390/mi12111408.
6
Regulating Strategies for Producing Carbohydrate Active Enzymes by Filamentous Fungal Cell Factories.丝状真菌细胞工厂生产碳水化合物活性酶的调控策略
Front Bioeng Biotechnol. 2020 Jul 8;8:691. doi: 10.3389/fbioe.2020.00691. eCollection 2020.
7
In-Solution IgG Titer Determination in Fermentation Broth Using Affibodies and Flow-Induced Dispersion Analysis.使用亲和体和流动诱导分散分析测定发酵液中的溶液内IgG滴度
ACS Omega. 2020 Apr 28;5(18):10519-10524. doi: 10.1021/acsomega.0c00791. eCollection 2020 May 12.
8
Fluorescence-based method is more accurate than counting-based methods for plotting growth curves of adherent cells.对于绘制贴壁细胞的生长曲线,基于荧光的方法比基于计数的方法更准确。
BMC Res Notes. 2020 Feb 4;13(1):57. doi: 10.1186/s13104-020-4914-8.
9
Innovation in Cell Banking, Expansion, and Production Culture.细胞库、细胞扩增及生产培养方面的创新。
Adv Biochem Eng Biotechnol. 2018;165:51-74. doi: 10.1007/10_2016_56.
10
Generation and characterization of a potentially applicable Vero cell line constitutively expressing the Schmallenberg virus nucleocapsid protein.一种组成型表达施马伦贝格病毒核衣壳蛋白的潜在适用Vero细胞系的产生与特性分析
Cytotechnology. 2017 Feb;69(1):145-156. doi: 10.1007/s10616-016-0046-3. Epub 2017 Jan 12.